23-999-113
Chembio Diagnostic Systems, Inc. DPP HIV-Syphilis
Manufacturer: Chembio Diagnostic Systems, Inc.
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Pack of 20 | 23-999-113-Pack-of-20 | In Stock | ₹ 42,097.00 |
23-999-113 - Pack of 20
In Stock
Quantity
1
Base Price: ₹ 42,097.00
GST (18%): ₹ 7,577.46
Total Price: ₹ 49,674.46
Certifications/Compliance
CLIA Waived
Control Sets
N/A - test device kit
Clia Complexity
Waived
Sample Type
Fingerstick whole blood, venous whole blood, or plasma
Packaging Type
Kit
Content And Storage
2°C to 25°C
CE Marker
Yes
Detectable Analytes
HIV, T. pallidum
For Use With (Application)
Chembio DPP Rapid Test
Quantity
20 Tests/Kit
Related Products
Description
- This test utilizes our patented Dual Path Platform (DPP) technology, provides results in 15 minutes, is easy to use and can be stored at room temperature
- This test is a single-use rapid, qualitative, multiplex, immunoassay for the detection of antibodies to HIV-1/2, and/or Treponema pallidum bacteria (the causative agent of syphilis) in fingerstick whole blood, venous whole blood or plasma specimens
- Patented DPP technology allows for higher sensitivity: >99% for HIV and >94% for T
- pallidum Only requires 10 μL of either fingerstick whole blood, venous whole blood or plasma Provides results in 15 minutes and is read with the DPP Micro Reader Combined reimbursement: CPT Codes 86703, 86780
SAFETY INFORMATION
- ShelfLife : 24 Months from DOM
Compare Similar Items
Show Difference
Certifications/Compliance: CLIA Waived
Control Sets: N/A - test device kit
Clia Complexity: Waived
Sample Type: Fingerstick whole blood, venous whole blood, or plasma
Packaging Type: Kit
Content And Storage: 2°C to 25°C
CE Marker: Yes
Detectable Analytes: HIV, T. pallidum
For Use With (Application): Chembio DPP Rapid Test
Quantity: 20 Tests/Kit
Certifications/Compliance:
CLIA Waived
Control Sets:
N/A - test device kit
Clia Complexity:
Waived
Sample Type:
Fingerstick whole blood, venous whole blood, or plasma
Packaging Type:
Kit
Content And Storage:
2°C to 25°C
CE Marker:
Yes
Detectable Analytes:
HIV, T. pallidum
For Use With (Application):
Chembio DPP Rapid Test
Quantity:
20 Tests/Kit
Certifications/Compliance: Moderately Complex
Control Sets: One HIV-1 / Syphilis Reactive Control, One HIV-2 Reactive Control, One Non-reactive Control
Clia Complexity: Moderate
Sample Type: Fingerstick whole blood, venous whole blood, or plasma
Packaging Type: 1 kit (contains 3 vials)
Content And Storage: 2°C to 8°C
CE Marker: Yes
Detectable Analytes: HIV, T. pallidum
For Use With (Application): Assay Controls
Quantity: 1 Set of Controls
Certifications/Compliance:
Moderately Complex
Control Sets:
One HIV-1 / Syphilis Reactive Control, One HIV-2 Reactive Control, One Non-reactive Control
Clia Complexity:
Moderate
Sample Type:
Fingerstick whole blood, venous whole blood, or plasma
Packaging Type:
1 kit (contains 3 vials)
Content And Storage:
2°C to 8°C
CE Marker:
Yes
Detectable Analytes:
HIV, T. pallidum
For Use With (Application):
Assay Controls
Quantity:
1 Set of Controls
Certifications/Compliance: __
Control Sets: __
Clia Complexity: __
Sample Type: __
Packaging Type: __
Content And Storage: __
CE Marker: __
Detectable Analytes: __
For Use With (Application): __
Quantity: __
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
__
Sample Type:
__
Packaging Type:
__
Content And Storage:
__
CE Marker:
__
Detectable Analytes:
__
For Use With (Application):
__
Quantity:
__
Certifications/Compliance: __
Control Sets: __
Clia Complexity: Waived
Sample Type: Direct Nasal Swab
Packaging Type: __
Content And Storage: 15°C to 30°C
CE Marker: Yes
Detectable Analytes: SARS-CoV-2 Antigens
For Use With (Application): Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Quantity: 50 Tests/Kit
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
Waived
Sample Type:
Direct Nasal Swab
Packaging Type:
__
Content And Storage:
15°C to 30°C
CE Marker:
Yes
Detectable Analytes:
SARS-CoV-2 Antigens
For Use With (Application):
Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Quantity:
50 Tests/Kit